Ethics approval and consent to participate.

AS Anna M. Seekatz
MS Matthew K. Schnizlein
MK Mark J. Koenigsknecht
JB Jason R. Baker
WH William L. Hasler
BB Barry E. Bleske
VY Vincent B. Young
DS Duxin Sun
request Request a Protocol
ask Ask a question
Favorite

Samples collected in this study were part of clinical trial NCT01999400. The institutional review boards at the University of Michigan (IRBMED) and the Department of Health and Human Services, Food and Drug Administration (Research Involving Human Subjects Committee [RIHSC]), both approved the study protocol (IRB approved on 4 February 2015). All subjects provided written informed consent in order to participate. Informed consent was obtained from individuals prior to the time of sampling.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A